RecallHawk

MONO-LINYAH (NORGESTIMATE AND ETHINYL ESTRADIOL)

NOVAST LABS LTD

Summary

FDA approved MONO-LINYAH (NORGESTIMATE AND ETHINYL ESTRADIOL) by NOVAST LABS LTD. ANDA (Generic) approval (Labeling) on 2022-04-29. TABLET, ORAL-28.

Details

Source

Drug Approval

External ID

ANDA090523-9

Action Date

2022-04-29

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

MONO-LINYAH (generic: NORGESTIMATE AND ETHINYL ESTRADIOL), TABLET, ORAL-28. Application: ANDA090523

Context & Analysis

NOVAST LABS LTD has 2 FDA actions in our database.

Frequently Asked Questions

How often does NOVAST LABS LTD have FDA actions?

NOVAST LABS LTD has 2 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA090523-9" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions